Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients

被引:8
作者
Barisione, Giovanni [1 ]
Bacigalupo, Andrea [1 ]
Brusasco, Claudia [2 ]
Scanarotti, Chiara [3 ]
Penco, Susanna [3 ]
Bassi, Anna Maria [3 ]
Lamparelli, Teresa [1 ]
Garlaschi, Alessandro [1 ]
Pellegrino, Riccardo [4 ]
Brusasco, Vito [2 ]
机构
[1] IRCCS Azienda Osped Univ San Martino IST, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Interna & Specialita Med, Genoa, Italy
[3] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
[4] Azienda Osped S Croce & Carle, Cuneo, Italy
关键词
Carbon monoxide; Nitric oxide; Alveolar-capillary membrane conductance; Pulmonary capillary volume; Reactive oxygen metabolites; Lung density; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; IDIOPATHIC PNEUMONIA SYNDROME; SIGNIFICANT BLOOD RESISTANCE; NITRIC-OXIDE TRANSFER; LONG-TERM SURVIVORS; C-REACTIVE PROTEIN; CARBON-MONOXIDE; LUNG-FUNCTION; LYMPHOMA PATIENTS;
D O I
10.1016/j.resp.2014.01.018
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Lung diffusing capacity for CO (DLCO) is compromised in haematopoietic stem-cell transplantation (HSCT) recipients. We derived alveolar-capillary membrane conductance (D-M,D-CO) and pulmonary capillary volume (V-C) from DLCO and diffusing capacity for NO (DLNO). Forty patients were studied before and 6 weeks after HSCT. Before HSCT, DLNO and DLCO were significantly lower than in 30 healthy controls. D-M,D-CO was similar to 40% lower in patients than in controls (p < 0.001), whereas V-C did not differ significantly. After HSCT, DLNO and D-M,D-CO further decreased, the latter by similar to 22% from before HSCT (p < 0.01) while V-C did not change significantly. Lung density, serum CRP and reactive oxygen metabolites were significantly increased, with the latter being correlated (R-2 = 0.71, p < 0.001) with the decrement in DLNO. We conclude that DLNO and, to a lesser extent, DLCO are compromised before HSCT mainly due to a D-M,D-CO reduction. A further reduction of D-M,D-CO without V-C loss occurs after HSCF, possibly related to development of oedema, or interstitial fibrosis, or both. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:54 / 61
页数:8
相关论文
共 50 条
  • [21] Decreased Physical Activity and Endurance Capacity in Patients Qualified for Haematopoietic Stem Cell Transplantation (HSCT)
    Chmielewski, Michal
    Szeremet, Agnieszka
    Stefanska, Malgorzata
    Jablonowska-Babij, Paula
    Majcherek, Maciej
    Czyz, Anna
    Wrobel, Tomasz
    Malicka, Iwona
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [22] A general practitioner's guide to hematopoietic stem-cell transplantation
    Bazinet, A.
    Popradi, G.
    CURRENT ONCOLOGY, 2019, 26 (03) : 187 - 191
  • [23] EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning
    Cohen, Jonathan M.
    Cooper, Nichola
    Chakrabarti, Suparno
    Thomson, Kirsty
    Samarasinghe, Sujith
    Cubitt, David
    Lloyd, Cathryn
    Woolfrey, Ann
    Veys, Paul
    Amrolia, Persis J.
    LEUKEMIA & LYMPHOMA, 2007, 48 (02) : 256 - 269
  • [24] Stem-cell transplantation in patients with germ cell tumors
    Linkesch, W
    ACTA MEDICA AUSTRIACA, 2000, 27 : 30 - 32
  • [25] Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
    Shimoni, A.
    Shem-Tov, N.
    Chetrit, A.
    Volchek, Y.
    Tallis, E.
    Avigdor, A.
    Sadetzki, S.
    Yerushalmi, R.
    Nagler, A.
    LEUKEMIA, 2013, 27 (04) : 829 - 835
  • [26] Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
    Johansson, J-E
    Remberger, M.
    Lazarevic, V. Lj
    Hallbook, H.
    Wahlin, A.
    Kimby, E.
    Juliusson, G.
    Omar, H.
    Hagglund, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 (06) : 870 - 875
  • [27] STEM-CELL TRANSPLANTATION - PAST, PRESENT AND FUTURE
    THOMAS, ED
    STEM CELLS, 1994, 12 (06) : 539 - 544
  • [28] Role of Stem-Cell Transplantation in Leukemia Treatment
    Dessie, Gashaw
    Molla, Meseret Derbew
    Shibabaw, Tewodros
    Ayelign, Birhanu
    STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2020, 13 : 67 - 77
  • [29] Hematopoietic stem-cell transplantation in aplastic anemia
    Hernández-Rivera, EG
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2005, 57 (02): : 298 - 304
  • [30] Haematopoietic stem cell transplantation for acquired aplastic anaemia
    Young, Moya E.
    Potter, Victoria
    Kulasekararaj, Austin G.
    Mufti, Ghulam J.
    Marsh, Judith C.
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (06) : 515 - 520